SCHEMBL3653144

SCHEMBL3653144

CC(C)(C)n1sc(-c2ccccc2)c(NCC(O)CO)c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.36
CHEK1 O14757 1/20 0.33
CDK1 P06493 1/20 0.33
PRKDC P78527 1/20 0.33
SYK P43405 1/20 0.32
ADRB2 P07550 2/20 0.32
ADRB1 P08588 1/20 0.32
CCNE2 O96020 1/20 0.32
CCNE1 P24864 1/20 0.32
CDK2 P24941 1/20 0.32
EGFR P00533 1/20 0.32
SRC P12931 1/20 0.32
SLC6A2 P23975 1/20 0.32
CA12 O43570 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
ABCB1 P08183 2/20 0.31
P2RY12 Q9H244 1/20 0.31
KCNA5 P22460 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5184298 0.84 CA12 (0.33) SLC6A2CA12CA2CA9KCNH2
SCHEMBL17844227 0.81 POLB (0.39) SMN1; SMN2CDK1SYKCDK2CA12
SCHEMBL5329025 0.80 SMN1; SMN2 (0.35) SMN1; SMN2CHEK1CDK1PRKDCCCNE2
SCHEMBL3551960 0.79 BRD4 (0.39) SMN1; SMN2
SCHEMBL17844088 0.76 KDM4E (0.40) SMN1; SMN2CA12CA2CA9
SCHEMBL17844175 0.75 CA12 (0.38) CA12CA2CA9
SCHEMBL17844110 0.74 MAOA (0.40)
SCHEMBL17844119 0.73 TAAR1 (0.40)
SCHEMBL17844244 0.70 MTNR1A (0.40)
SCHEMBL17844236 0.70 DRD2 (0.44) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7723333-B2 Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators ASTRAZENECA AB (SE) 2010-05-25 US claimed
WO-2016100619-A2 TREATMENT AND DIAGNOSIS OF CANCER RGENIX, INC. (US) 2016-06-23 WO disclosed